Donald R. Miller

Donald R. Miller

Auto-generated profile, based on publicly available information

Donald R. Miller

Boston University School of Public Health, VA Boston Health Care, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
DMDonald R. Miller
Donald R. Miller
MSMonika M. Safford
Monika M. Safford
LPLeonard M. Pogach
Leonard M. Pogach
OBJECTIVE—To optimize methods for identifying patients with diabetes based on computerized records and to obtain best estimates of diabetes prevalence in Department of Veterans Affairs (VA) patients. RESEARCH DESIGN AND METHODS—The VA Diabetes Epidemiology Cohort (DEpiC) is a linked national database of all VA patients since 1998 with data from VA medical visits, Medicare claims, pharmacy and laboratory records, and patient surveys. Using DEpiC, we examined concordance of diabetes indicators, including ICD-9-CM codes (250.xx), prescription drug treatment, HbA1c tests, and patient self-report. We determined the optimal criterion for identifying diabetes and used it in estimating diabetes prevalence in the VA. RESULTS—The best criterion was a prescription for a diabetes medication in the current year and/or 2+ diabetes codes from inpatient and/or outpatient visits (VA and Medicare) over a 24-month period. This definition had high sensitivity (93%) and specificity (98%) against patient self-report, and reasonable rates of HbA1c testing (75%). HbA1c testing alone added few additional cases, and a single diagnostic code added many patients, but without confirmation (reduced specificity). However, including codes from Medicare was critical. Applying this definition for 1998–2000, we identified an average of 500,000 VA patients with diabetes per year. We also estimated high and increasing diabetes prevalence rates of 16.7% in FY1998, 18.6% in FY1999, and 19.6% in FY2000 and an incidence estimated to be ∼2% per year. CONCLUSIONS—Development and evaluation of methodology for analyzing computerized patient data can improve the identification of patients with diabetes. The increasing high prevalence of diabetes in VA patients will present challenges for clinicians and health system management.

1 June 2008 in Hypertension
Verified
Journal Article
Closed access
PDF file
DMDonald R. Miller
Donald R. Miller
SOSusan A. Oliveria
Susan A. Oliveria
DBDan R. Berlowitz
Dan R. Berlowitz
BFBenjamin G. Fincke
Benjamin G. Fincke
PSPaul Stang
Paul Stang
DLDavid E. Lillienfeld
David E. Lillienfeld
Angioedema is a rare but potentially serious complication of angiotensin-converting enzyme inhibitor (ACE) use. We conducted a study to estimate incidence of ACE-related angioedema and explore its determinants in a large racially diverse patient population. We used linked medical and pharmacy records to identify all patients in the US Veterans Affairs Health Care System from April 1999 through December 2000 who received first prescriptions for antihypertensive medications. We studied 195 192 ACE initiators and 399 889 patients initiating other antihypertensive medications (OAH). New angioedema was identified by diagnosis codes using methods validated in a national sample of 869 angioedema cases with confirmation for over 95% of cases. Overall, 0.20% of ACE initiators developed angioedema while on the medication and the incidence rate was 1.97 (1.77 to 2.18) cases per 1000 person years. This compares with a rate of 0.51 (0.43 to 0.59) in OAH initiators and the adjusted relative risk estimate was 3.56 (2.82 to 4.44). Fifty five percent of cases occurred within 90 days of first ACE use but risk remained elevated with prolonged use, even beyond 1 year. We estimate that 58.3% of angioedema in patients starting antihypertensives was related to ACE. We also found that angioedema rates were nearly 4-fold higher in blacks, 50% higher in women, and 12% lower in those with diabetes. This study provides a reliable estimate of angioedema incidence associated with ACE use in a diverse nontrial patient population, confirming that the incidence is low, but finding substantial variation by race, sex, and diabetes status.

6 July 2010 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
BFBenjamin G Fincke
Benjamin G Fincke
DMDonald R Miller
Donald R Miller
RTRobin Turpin
Robin Turpin
Diabetic foot infections are common, serious, and varied. Diagnostic and treatment strategies are correspondingly diverse. It is unclear how patients are managed in actual practice and how outcomes might be improved. Clarification will require study of large numbers of patients, such as are available in medical databases. We have developed and evaluated a system for identifying and classifying diabetic foot infections that can be used for this purpose.

25 March 2015 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
CTChin-Lin Tseng
Chin-Lin Tseng
JLJean-Philippe Lafrance
Jean-Philippe Lafrance
SLShou-En Lu
Shou-En Lu
OSOrysya Soroka
Orysya Soroka
DMDonald R Miller
Donald R Miller
LPLeonard M Pogach
Leonard M Pogach
It is unknown whether variability of estimated Glomerular Filtration Rate (eGFR) is a risk factor for dialysis or death in patients with chronic kidney disease (CKD). This study aimed to evaluate variability of estimated Glomerular Filtration Rate (eGFR) as a risk factor for dialysis or death to facilitate optimum care among high risk patients. A longitudinal retrospective cohort study of 70,598 Veterans Health Administration veteran patients with diabetes and CKD (stage 3–4) in 2000 with up to 5 years of follow-up. VHA and Medicare files were linked to derive study variables. We used Cox proportional hazards models to evaluate association between time to initial dialysis/death and key independent variables: time-varying eGFR variability (measured by standard deviation (SD)) and eGFR means and slopes while adjusting for prior hospitalizations, and comorbidities. There were 76.7% older than 65 years, 97.5% men, and 81.9% Whites. Patients were largely in early stage 3 (61.2%), followed by late stage 3 (28.9%), and stage 4 (9.9%); 29.1%, 46.8%, and 73.3%, respectively, died or had dialysis during the follow-up. eGFR SDs (median: 5.8, 5.1, and 4.0 ml/min/1.73 m2 ) and means (median: 54.1, 41.0, 27.2 ml/min/1.73 m2) from all two-year moving intervals decreased as CKD advanced; eGFR variability (relative to the mean) increased when CKD progressed (median coefficient of variation: 10.9, 12.8, and 15.4). Cox regressions revealed that one unit increase in a patient’s standard deviation of eGFRs from prior two years was significantly associated with about 7% increase in risk of dialysis/death in the current year, similarly in all three CKD stages. This was after adjusting for concurrent means and slopes of eGFRs, demographics, prior hospitalization, and comorbidities. For example, the hazard of dialysis/death increased by 7.2% (hazard ratio:1.072; 95% CI = 1.067, 1.080) in early stage 3. eGFR variability was independently associated with elevated risk of dialysis/death even after controlling for eGFR means and slopes.

1 April 2008 in Journal of Ambulatory Care Management
Verified
Journal Article
Closed access
DMDonald R. Miller
Donald R. Miller
WRWilliam H. Rogers
William H. Rogers
LKLewis Kazis
Lewis Kazis
Avron SpiroAvron Spiro
Avron Spiro
XRXinhua S. Ren
Xinhua S. Ren
SHSamuel C. Haffer
Samuel C. Haffer
We evaluated the patient self-report questions about disease from the Medicare Health Outcomes Survey (HOS), using linked Veterans Health Administration (VA) data for patients who are eligible for both Medicare and Veterans Affairs (VA) care to estimate their utility as measures of illness burden. Patients were classified for 12 diseases on the basis of HOS question responses and these were compared with classifications based on similar questions from a VA survey or diagnostic codes from VA medical records. Agreement between classifications based on the 2 surveys was good with over 75% of patients affirming the disease in the HOS also affirming it in the VA survey for most diseases. HOS disease status also agreed well with VA-based disease status using diagnostic codes for most diseases, with reasonably good specificity (70%-94%) and sensitivity (65%-85%). The relatively poor measures of agreement for some of the conditions could be related to differences in question wording and other factors. These findings varied only slightly by education, age, and race. Furthermore, independent decrements in health status, derived from the SF-36 associated with each disease based on the survey questions, were similar in the 2 surveys. These results suggest that patients can provide reasonably good reports of their morbidity in survey questions and that patient self-report questions about disease can be used reliably in case-mix adjustments and in stratifications of patients by diseases.

6 July 2010 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
BFBenjamin G Fincke
Benjamin G Fincke
DMDonald R Miller
Donald R Miller
CCCindy L Christiansen
Cindy L Christiansen
RTRobin S Turpin
Robin S Turpin
Diabetic foot infections are common, serious, and diverse. There is uncertainty about optimal antibiotic treatment, and probably substantial variation in practice. Our aim was to document whether this is the case: A finding that would raise questions about the comparative cost-effectiveness of different regimens and also open the possibility of examining costs and outcomes to determine which should be preferred.